ELAPRASE Side Effects

7018572-X | Rash, Supraventricular Tachycardia
on Sep 24, 2010 Male patient from BRAZIL , child 4 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), supraventricular tachycardia. Elaprase dosage: . Patient was hospitalized.

6939220-0 | Respiratory Failure
Patient was taking Elaprase (View Usage). Patient had the following side effects: respiratory failure on Aug 20, 2010 from BRAZIL Additional patient health information: Male patient , 19 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: .

6921764-9 | Cough, Dysphonia, Infusion Related Reaction, Oedema, Urticaria
Adverse event was reported on Aug 02, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: 18 Mg, 1x/week) was diagnosed with mucopolysaccharidosis ii and. Location: AUSTRALIA , weighting 84.22 lb, After Elaprase was administered, patient had the following side effects: cough, dysphonia, infusion related reaction, oedema, urticaria. During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6921170-7 |
on Aug 06, 2010 Male patient from UNITED STATES , weighting 53.99 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). . Elaprase dosage: 18 Mg, 1x/week.


6918238-8 | Cough, Dysphonia, Infusion Related Reaction, Oedema, Urticaria
on Aug 02, 2010 Male patient from AUSTRALIA , weighting 84.22 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient had the following side effects: cough, dysphonia, infusion related reaction, oedema, urticaria. Elaprase dosage: 18 Mg, 1x/week. During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6814593-8 | Anaphylactoid Reaction, Infusion Related Reaction
Patient was taking Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: anaphylactoid reaction, infusion related reaction on Jul 13, 2009 from BRAZIL Additional patient health information: Male patient , weighting 65.04 lb, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: .5 Mg/kg, 1x/week.

6744175-8 | Bronchospasm, Hypotension, Infusion Related Reaction, Pyrexia
Adverse event was reported on May 26, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: ) was diagnosed with mucopolysaccharidosis ii and. Location: SPAIN , 13 years of age, Patient experienced the following unwanted or unexpected effects: bronchospasm, hypotension, infusion related reaction, pyrexia. During the same period patient was treated with POLARAMINE /00043702/ (View Polaramine /00043702/ Review and Polaramine /00043702/ Label ), RANITIDINE /00550802/ (View Ranitidine /00550802/ Review and Ranitidine /00550802/ Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ). Patient was hospitalized.

6741250-9 |
on May 19, 2010 Male patient from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , weighting 66.14 lb, was diagnosed with mucopolysaccharidosis ii, nasopharyngitis and was treated with Elaprase (View Usage). . Elaprase dosage: .5 Mg/kg, 1x/week. During the same period patient was treated with HYDROXYZINE (10 Ml, 1x/day:qd) (View Hydroxyzine Review and Hydroxyzine Label ), CEFACLOR (250 Mg, 2x/day:bid) (View Cefaclor Review and Cefaclor Label ), BIOFLOR /00838001/ (250 Mg, 2x/day:bid) (View Bioflor /00838001/ Review and Bioflor /00838001/ Label ), MEPHIROL (7 Ml, 3x/day:tid) (View Mephirol Review and Mephirol Label ).

6712490-X | Respiratory Tract Haemorrhage
on Apr 30, 2010 Male patient from JAPAN , 22 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: respiratory tract haemorrhage. Elaprase dosage: .

6708911-9 | Asthma, Disease Progression, Pneumonia
Patient was taking Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), disease progression, pneumonia (What is pneumonia?) on Apr 14, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 42 Mg, 1x/week; Iv Drip. Patient was hospitalized.

6697699-6 | Post Procedural Infection, Respiratory Tract Infection Viral
Adverse event was reported on Apr 09, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: 12 Mg, 1x/week, Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: UNITED STATES , child 5 years of age, Patient had the following side effects: post procedural infection, respiratory tract infection viral. Patient was hospitalized.

6697047-1 | Blood Immunoglobulin G Increased, Chills, Eye Oedema, Infusion Related Reaction, Neutralising Antibodies Positive, Peripheral Circulatory Failure, Pyrexia, Rash Macular, Respiratory Distress
on Apr 08, 2010 Male patient from UNITED KINGDOM , child 3 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: blood immunoglobulin g increased, chills, eye oedema, infusion related reaction, neutralising antibodies positive, peripheral circulatory failure, pyrexia, rash macular, respiratory distress. Elaprase dosage: 6 Mg, 1x/week, Iv Drip; 12 Mg, Other, Iv Drip. During the same period patient was treated with HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6695797-4 | Bronchospasm, Hypotension, Infusion Related Reaction, Pyrexia
on Apr 07, 2010 Male patient from SPAIN , 13 years of age, was diagnosed with hypotension, infusion related reaction and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, hypotension, infusion related reaction, pyrexia. Elaprase dosage: 0.5 Mg/kg, 1x/week, Iv Drip. During the same period patient was treated with POLARAMINE (View Polaramine Review and Polaramine Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6683603-3 | Pneumonia, Pyrexia
Patient was taking Elaprase (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), pyrexia on Mar 31, 2010 from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF Additional patient health information: Male patient , 26 years of age, weighting 84.44 lb, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 0.5 Mg/kg, 1x/week, Iv Drip. Patient was hospitalized.

6672782-X | Device Related Infection, Obstructive Airways Disorder, Post Procedural Complication, Respiratory Arrest
Adverse event was reported on Mar 25, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: 4 Df, 1x/ Week, Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: UNITED STATES , 15 years of age, After Elaprase was administered, patient had the following side effects: device related infection, obstructive airways disorder, post procedural complication, respiratory arrest. Patient was hospitalized.

6672160-3 | Complications Of Bone Marrow Transplant, Pneumonia
on Mar 24, 2010 Male patient from KOREA, REPUBLIC OF , 26 years of age, weighting 84.44 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: complications of bone marrow transplant, pneumonia (What is pneumonia?). Elaprase dosage: 0.5 Mg/kg, 1x/ Week, Iv Drip. Patient was hospitalized.

6668892-3 | Eyelid Oedema, Hypersensitivity, Infusion Related Reaction, Respiratory Disorder, Urticaria
on Mar 17, 2010 Female patient from JAPAN , child 9 years of age, weighting 61.73 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient had the following side effects: eyelid oedema, hypersensitivity, infusion related reaction, respiratory disorder, urticaria. Elaprase dosage: 13.5 Mg, Iv Drip. During the same period patient was treated with LORATADINE (View Loratadine Review and Loratadine Label ), HYDROXYZINE PAMOATE (View Hydroxyzine Pamoate Review and Hydroxyzine Pamoate Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), HYDROCORTISONE SODIUM SUCCINATE (View Hydrocortisone Sodium Succinate Review and Hydrocortisone Sodium Succinate Label ).

6665610-X | Apnoea, Obstructive Airways Disorder, Post Procedural Complication, Respiratory Disorder, Respiratory Distress, Tooth Disorder, Tooth Impacted
Patient was taking Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: apnoea, obstructive airways disorder, post procedural complication, respiratory disorder, respiratory distress, tooth disorder (What is tooth disorder?), tooth impacted on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 15 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 4 Df, 1x/week, Iv Drip. Patient was hospitalized.

6665209-5 | Central Venous Catheterisation, Convulsion, Cough, Grand Mal Convulsion, Increased Bronchial Secretion, Infusion Related Reaction, Tachycardia
Adverse event was reported on Mar 18, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: 0.5 Mg/kg, Unk, Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: MEXICO , child 9 years of age, Patient experienced the following unwanted or unexpected effects: central venous catheterisation, convulsion, cough, grand mal convulsion, increased bronchial secretion, infusion related reaction, tachycardia. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), OXCARBAZEPINE (OXYCARBAZEPINE) (View Oxcarbazepine (oxycarbazepine) Review and Oxcarbazepine (oxycarbazepine) Label ). Patient was hospitalized.

6664982-X | Bone Marrow Transplant, Post Procedural Pneumonia, Pyrexia
on Mar 22, 2010 Male patient from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , 26 years of age, weighting 84.44 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient had the following side effects: bone marrow transplant (What is bone marrow transplant?), post procedural pneumonia, pyrexia. Elaprase dosage: 0.5 Mg/kg, 1x/week, Iv Drip. Patient was hospitalized.

6664814-X | Anaphylactoid Reaction, Infusion Related Reaction
on Mar 15, 2010 Male patient from JAPAN , 13 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: anaphylactoid reaction, infusion related reaction. Elaprase dosage: 12 Mg, 1x/week, Iv Drip. During the same period patient was treated with HYDROXYZINE HCL (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ), HYDROCORTISONE SODIUM SUCCINATE (View Hydrocortisone Sodium Succinate Review and Hydrocortisone Sodium Succinate Label ), POLARAMINE (View Polaramine Review and Polaramine Label ), OXATOMIDE (View Oxatomide Review and Oxatomide Label ), PHENOBARBITAL /00023202/ (PHENOBARBITAL SODIUM) (View Phenobarbital /00023202/ (phenobarbital Sodium) Review and Phenobarbital /00023202/ (phenobarbital Sodium) Label ), AMBROX (AMBROXOL HYDROCHLORIDE) (View Ambrox (ambroxol Hydrochloride) Review and Ambrox (ambroxol Hydrochloride) Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUDOSTEINE (FUDOSTEINE) (View Fudosteine (fudosteine) Review and Fudosteine (fudosteine) Label ). Patient was hospitalized.

6655221-4 | Respiratory Distress
Patient was taking Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory distress on Mar 19, 2010 from UNITED STATES Additional patient health information: Male patient , child 9 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: Iv Drip. Patient was hospitalized.

6655216-0 | Aspiration
Adverse event was reported on Mar 11, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: 7 Df, 1x/week, Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: UNITED STATES , 42 years of age, Patient had the following side effects: aspiration. Patient was hospitalized.

6652500-1 | Anaphylactoid Reaction, Infusion Related Reaction
on Mar 15, 2010 Male patient from JAPAN , 13 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: anaphylactoid reaction, infusion related reaction. Elaprase dosage: 12 Mg, 1x/week, Iv Drip. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), AMBROXOL HYDROCHLORIDE (AMBROXOL HYDROCHLORIDE) (View Ambroxol Hydrochloride (ambroxol Hydrochloride) Review and Ambroxol Hydrochloride (ambroxol Hydrochloride) Label ), ERYTHROMYCIN ETHYLSUCCINATE (View Erythromycin Ethylsuccinate Review and Erythromycin Ethylsuccinate Label ), FUDOSTEINE (FUDOSTEINE) (View Fudosteine (fudosteine) Review and Fudosteine (fudosteine) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), SODIUM CHLORIDE 0.9% (View Sodium Chloride 0.9% Review and Sodium Chloride 0.9% Label ). Patient was hospitalized.

6652288-4 | Hernia
on Mar 08, 2010 Male patient from UNITED STATES , 28 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: hernia (What is hernia?). Elaprase dosage: . Patient was hospitalized.

6621889-1 | Grand Mal Convulsion
Patient was taking Elaprase (View Usage). Patient had the following side effects: grand mal convulsion on Feb 16, 2010 from MEXICO Additional patient health information: Male patient , child 9 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 0.5 Mg/kg, Iv Drip. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

6621888-X | Bronchitis Bacterial, Erythema, Infusion Related Reaction, Oedema
Adverse event was reported on Feb 18, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: BRAZIL , weighting 53.79 lb, After Elaprase was administered, patient had the following side effects: bronchitis bacterial, erythema, infusion related reaction, oedema. During the same period patient was treated with BEROTEC (View Berotec Review and Berotec Label ). Patient was hospitalized.

6609377-X | Blood Pressure Decreased, Infusion Related Reaction, Oxygen Saturation Decreased
on Feb 12, 2010 Male patient from NETHERLANDS , 39 years of age, weighting 141.1 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, infusion related reaction, oxygen saturation decreased. Elaprase dosage: 32 Mg, 1x/week, Iv Drip. Patient was hospitalized.

6593790-3 | Aortic Valve Replacement, Respiratory Disorder, Respiratory Failure
on Jan 21, 2010 Male patient from UNITED STATES , 17 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient had the following side effects: aortic valve replacement, respiratory disorder, respiratory failure. Elaprase dosage: 3 Df, 1x/week, Iv Drip. Patient was hospitalized.

6592779-8 | Pneumonia
Patient was taking Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Jan 26, 2010 from UNITED STATES Additional patient health information: Male patient , child 4 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: Iv Drip. Patient was hospitalized.

6589720-0 | Disease Progression, Mucopolysaccharidosis Ii, Neurological Decompensation, Respiratory Arrest
Adverse event was reported on Jan 29, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: 0.5 Mg/kg, 1x/week, Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: UNITED STATES , child 12 years of age, weighting 67.68 lb, Patient experienced the following unwanted or unexpected effects: disease progression, mucopolysaccharidosis ii, neurological decompensation, respiratory arrest. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), SINGULAIR (View Singulair Review and Singulair Label ), VALIUM (View Valium Review and Valium Label ), GLUCOSAMINE (GLUCOSAMINE) (View Glucosamine (glucosamine) Review and Glucosamine (glucosamine) Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6580210-8 | Device Malfunction
on Jan 21, 2010 Male patient from ITALY , 56 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient had the following side effects: device malfunction. Elaprase dosage: .

6571321-1 | Body Temperature Increased, Breath Sounds Abnormal, Chills, Cyanosis, Oxygen Saturation Decreased, Respiratory Disorder, Respiratory Rate Increased
on Jan 19, 2010 Female patient from UNITED STATES , child 9 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: body temperature increased, breath sounds abnormal, chills, cyanosis, oxygen saturation decreased, respiratory disorder, respiratory rate increased. Elaprase dosage: Iv Drip.

6571320-X | Obstructive Airways Disorder, Respiratory Failure
Patient was taking Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: obstructive airways disorder, respiratory failure on Jan 20, 2010 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, weighting 68.34 lb, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 18 Mg, 1x/week,. During the same period patient was treated with MIRALAX (View Miralax Review and Miralax Label ), TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN (View Topical Products For Joint And Muscular Pain Review and Topical Products For Joint And Muscular Pain Label ).

6568000-3 | Eyelid Oedema, Infusion Related Reaction, Medical Device Complication, Urticaria
Adverse event was reported on Jan 14, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: Iv Drip) . Location: UNITED STATES , child 10 years of age, Patient had the following side effects: eyelid oedema, infusion related reaction, medical device complication, urticaria. During the same period patient was treated with CLARITIN /00413701/ (View Claritin /00413701/ Review and Claritin /00413701/ Label ), TYLENOL /00020001/ (PARACETAMOL) (View Tylenol /00020001/ (paracetamol) Review and Tylenol /00020001/ (paracetamol) Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ). Patient was hospitalized.

6556902-3 | Central Nervous System Lesion, Cerebral Atrophy, Cognitive Disorder, Condition Aggravated, Epilepsy
on Jan 11, 2010 Female patient from ITALY , child 11 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: central nervous system lesion, cerebral atrophy, cognitive disorder, condition aggravated, epilepsy (What is epilepsy?). Elaprase dosage: 0.5 Mg/kg, 1x/week, Iv Drip.

6553731-1 | Aspiration, Gastrointestinal Tube Insertion
on Jan 11, 2010 Male patient from UNITED STATES , child 10 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, gastrointestinal tube insertion. Elaprase dosage: 2 Df, 1x/week, Iv Drip. Patient was hospitalized.

6552595-X | Convulsion, Dizziness, Heart Rate Increased, Muscle Twitching
Patient was taking Elaprase (View Usage). Patient had the following side effects: convulsion, dizziness (What is dizziness?), heart rate increased, muscle twitching on Jan 06, 2010 from UNITED STATES Additional patient health information: Male patient , 29 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 8 Df,1 X/week. Patient was hospitalized.

6551164-5 | Cerebral Haemorrhage
Adverse event was reported on Jan 12, 2010 by a Male patient taking Elaprase (View Usage) (Dosage: Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: KOREA, REPUBLIC OF , 27 years of age, weighting 145.7 lb, After Elaprase was administered, patient had the following side effects: cerebral haemorrhage.

6539412-9 | Convulsion, Ear Infection, Petit Mal Epilepsy, Staring
on Dec 30, 2009 Male patient from UNITED STATES , child 7 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, ear infection (What is ear infection?), petit mal epilepsy, staring. Elaprase dosage: 2 Df, 1x/week, Iv Drip.

6538863-6 | Cough, Dysphonia, Infusion Related Reaction, Oedema, Urticaria
on Dec 30, 2009 Male patient from AUSTRALIA , child 10 years of age, weighting 84.22 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient had the following side effects: cough, dysphonia, infusion related reaction, oedema, urticaria. Elaprase dosage: 18 Mg, 1x/week, Iv Drip. During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6530576-X | Anaphylactic Reaction, Infusion Related Reaction
Patient was taking Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: anaphylactic reaction, infusion related reaction on Jan 06, 2010 from UNITED STATES Additional patient health information: Male patient , child 5 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 0.5 Mg/kg, 1x/week, Iv Drip. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ). Patient was hospitalized.

6527867-5 | Anaemia, Cyanosis, Dysphagia, Endocarditis Bacterial, Gastrooesophageal Reflux Disease, Heart Valve Calcification, Hydrocephalus, Hypoxia, Malnutrition
Adverse event was reported on Dec 18, 2009 by a Male patient taking Elaprase (View Usage) (Dosage: 6 Ml, 1x/week, Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: BRAZIL , 14 years of age, weighting 48.50 lb, Patient experienced the following unwanted or unexpected effects: anaemia, cyanosis, dysphagia, endocarditis bacterial, gastrooesophageal reflux disease, heart valve calcification, hydrocephalus (What is hydrocephalus?), hypoxia, malnutrition. Patient was hospitalized.

6527839-0 | Pneumonia
on Dec 21, 2009 Male patient from BRAZIL , 15 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Elaprase dosage: Iv Drip.

6523449-X | Respiratory Failure
on Dec 11, 2009 Male patient from BRAZIL , 14 years of age, weighting 48.50 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: respiratory failure. Elaprase dosage: 6 Ml, 1x/week, Iv Drip.

6521161-4 | Blood Potassium Decreased
Patient was taking Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased on Dec 15, 2009 from UNITED STATES Additional patient health information: Male patient , child 4 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: Iv Drip. Patient was hospitalized.

6484356-4 | Obstructive Airways Disorder
Adverse event was reported on Nov 19, 2009 by a Male patient taking Elaprase (View Usage) (Dosage: 0.5 Mg, 1x/week, Iv Drip) was diagnosed with mucopolysaccharidosis ii and. Location: FRANCE , child 9 years of age, Patient had the following side effects: obstructive airways disorder. Patient was hospitalized.

6480805-6 | Aspiration Tracheal Abnormal, Convulsion, Respiratory Arrest, Unresponsive To Stimuli
on Nov 19, 2009 Male patient from UNITED STATES , child 9 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). After Elaprase was administered, patient had the following side effects: aspiration tracheal abnormal, convulsion, respiratory arrest, unresponsive to stimuli. Elaprase dosage: Iv Drip.

6472344-3 | Blood Culture Positive, Infusion Site Infection
on Nov 17, 2009 Male patient from UNITED STATES , child 2 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase (View Usage). Patient experienced the following unwanted or unexpected effects: blood culture positive, infusion site infection. Elaprase dosage: Iv Drip. Patient was hospitalized.

6472341-8 | Hydrocephalus, Urticaria
Patient was taking Elaprase (View Usage). Patient had the following side effects: hydrocephalus (What is hydrocephalus?), urticaria on Nov 18, 2009 from UNITED STATES Additional patient health information: Male patient , child 9 years of age, was diagnosed with mucopolysaccharidosis ii and. Elaprase dosage: 1x/week, Iv Drip.